全球膝盖肿胀治疗市场

到 2030 年，全球膝盖肿胀治疗市场规模将达到 26 亿美元

全球膝关节肿胀治疗市场规模预计在2024年达到21亿美元，预计在2024-2030年的分析期内将以3.3%的复合年增长率增长，到2030年将达到26亿美元。药物治疗是本报告分析的细分市场之一，预计其复合年增长率为3.3%，到分析期结束时规模将达到9.122亿美元。病患自控式镇痛帮浦细分市场在分析期间的复合年增长率预计为4.1%。

美国市场规模估计为 5.773 亿美元，中国市场预计复合年增长率为 6.1%

美国膝关节肿胀治疗市场规模预计在2024年达到5.773亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到5.087亿美元，在2024-2030年的分析期内，复合年增长率为6.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.3%和2.5%。在欧洲，预计德国市场的复合年增长率为1.8%。

全球膝盖肿胀治疗市场－主要趋势与驱动因素摘要

膝盖肿胀的主要原因和问题有哪些？

膝关节肿胀是由膝关节内或周围积液引起的，是多种潜在疾病的症状，从急性损伤或感染疾病，到骨关节炎、类风湿性关节炎和痛风等慢性疾病。膝关节肿胀看似简单，但会严重影响活动能力，引发慢性疼痛，并降低生活品质。其复杂性在于准确的诊断、量身定制的治疗方案以及预防復发的长期管理。

在运动医学和老年医学领域，由于年轻人体力活动增加以及老年人预期寿命延长，膝盖肿胀的病例正在增加。肥胖和久坐的生活方式也会增加关节负担，是加速退化性病变的主要因素。治疗需要整形外科方法，包括骨科干预、物理治疗、药物治疗，有时还需要关节镜和关节关节重建等外科手术。

使用了哪些治疗方法和技术？

传统的膝关节肿胀治疗方法包括非类固醇抗发炎药物 (NSAID)、皮质类固醇注射、滑液抽吸和休息/冰疗。然而，一些更新的治疗方法正在被纳入治疗通讯协定中。这些疗法包括透明质酸注射、富血小板血浆 (PRP) 以及干细胞疗法等生物製药，所有这些疗法都旨在再生关节软骨并更持续地减轻发炎。

穿戴式膝关节矫正器具、压缩绷带以及嵌入感测器的智慧支撑等辅助技术也越来越受欢迎。这些设备不仅辅助运动，还能为监测治疗效果的临床医师提供即时数据。在復健领域，物理治疗正日益数位化，利用应用程式和远端医疗为患者提供个人化的復健练习。动态超音波和核磁共振等先进的成像技术正在提高诊断准确性，并促进早期疗育。

医疗保健和人口老化如何影响需求？

人口老化是全球膝关节肿胀治疗市场的主要驱动力，因为慢性膝关节肿胀最常见的原因之一是与老龄化相关的关节劣化。此外，年轻族群中运动伤害和肌肉骨骼问题的增加也正在扩大市场规模。医疗保健可近性的改善，尤其是在新兴经济体，正在改善诊断水平，并扩大接受高级治疗的患者群体。

健康意识提升宣传活动、预防性健康计划以及整形外科推广诊所正在鼓励患者更早就诊并更长期地接受治疗。许多地区门诊和物理治疗的保险覆盖率也得到了提高，这降低了经济障碍并增加了治疗量。此外，向门诊和家庭护理的转变也推动了对微创手术、穿戴式装置和数位监测工具的需求。

是什么推动了膝盖肿胀治疗市场的成长？

膝关节肿胀治疗市场的成长受到多种关键因素的推动，例如人口老化、整形外科疾病盛行率上升、运动伤害增加以及生物和非侵入性疗法的创新。对患者友善、有效且持久的治疗方案的需求，推动了再生医学、骨科生物学和智慧復健技术的研发。

医院对整形外科基础设施的投资，以及专科诊所和门诊手术中心的激增，进一步提升了市场的可近性。穿戴式监测和远距復健技术的进步，以及远端医疗的趋势，使得膝关节治疗更加积极、个人化。公共和私人医疗保险的支持、医生培训的加强以及病患教育的加强，也在市场上升趋势中发挥关键作用。

部分

类型（药物、病患自控镇痛帮浦、神经阻断、脂质体Bupivacaine、手术）、药物（鸦片类药物、皮质类固醇药物、其他药物）、手术（关节穿刺术、关节镜、膝关节关节重建）、最终使用者（医院最终使用者、指定诊所最终使用者、门诊手术中心最终使用者、其他最终使用者）

受访公司范例

• AbbVie Inc.
• AstraZeneca
• B. Braun Melsungen AG
• Bayer AG
• BD（Becton Dickinson）
• DePuy Synthes（Johnson & Johnson）
• Eli Lilly and Company
• Exactech Inc.
• Flexion Therapeutics, Inc.
• GlaxoSmithKline plc
• Johnson & Johnson（DePuy）
• Mathys（Enovis/previously Mathys AG）
• Merck & Co., Inc.
• Novartis International AG
• Ossur hf.
• Pfizer Inc.
• Sanofi SA
• Smith & Nephew plc
• Stryker Corporation
• Zimmer Biomet

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Swollen Knee Treatment Market to Reach US$2.6 Billion by 2030

The global market for Swollen Knee Treatment estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Medication, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$912.2 Million by the end of the analysis period. Growth in the Patient-Controlled Analgesia Pumps segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$577.3 Million While China is Forecast to Grow at 6.1% CAGR

The Swollen Knee Treatment market in the U.S. is estimated at US$577.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$508.7 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Swollen Knee Treatment Market - Key Trends & Drivers Summarized

What Are the Core Causes and Challenges of Swollen Knee Conditions?

Swollen knees-resulting from fluid buildup within or around the knee joint-are symptomatic of a wide array of underlying conditions, from acute injuries and infections to chronic diseases such as osteoarthritis, rheumatoid arthritis, and gout. While seemingly simple, swollen knees can significantly impair mobility, cause chronic pain, and reduce quality of life. The complexity lies in accurate diagnosis, tailored treatment plans, and long-term management to prevent recurrence.

In both sports medicine and geriatric care, swollen knee cases are rising due to increased physical activity among youth and longer life expectancy among older populations. Obesity and sedentary lifestyles are also major contributors, exacerbating pressure on the joints and accelerating degenerative changes. Treatment requires a multidisciplinary approach, including orthopedic intervention, physical therapy, pharmacology, and sometimes surgical procedures such as arthroscopy or joint replacement.

What Therapies and Technologies Are Being Used for Treatment?

Conventional treatments for swollen knees include NSAIDs, corticosteroid injections, aspiration of synovial fluid, and rest/ice therapy. However, new therapeutic methods are being integrated into treatment protocols. These include biologics like hyaluronic acid injections, platelet-rich plasma (PRP), and stem cell therapy, all aimed at regenerating joint cartilage and reducing inflammation more sustainably.

Assistive technologies such as wearable knee braces, compression wraps, and intelligent supports embedded with sensors are also gaining popularity. These devices not only aid movement but provide real-time data to clinicians monitoring treatment efficacy. In rehabilitation, physical therapy has become increasingly digitized, using apps and telehealth to guide patients through customized recovery exercises. Advanced imaging techniques like dynamic ultrasound and MRI are improving diagnostic precision, facilitating early intervention.

How Are Healthcare Access and Aging Demographics Affecting Demand?

Globally, the aging population is a key driver of the swollen knee treatment market, as age-related joint deterioration is among the most common causes of chronic knee swelling. Additionally, rising sports injuries and musculoskeletal issues in younger populations are widening the market demographic. Increased healthcare access-particularly in emerging economies-is also improving diagnosis and expanding the patient pool eligible for advanced therapies.

Health awareness campaigns, preventive wellness programs, and orthopedic outreach clinics are encouraging earlier consultation and long-term treatment adherence. Insurance coverage for outpatient treatments and physical therapy has also improved in many regions, reducing financial barriers and boosting procedural volumes. Moreover, the shift toward outpatient and home-based care is driving demand for minimally invasive procedures, wearables, and digital monitoring tools.

What’s Fueling the Growth in the Swollen Knee Treatment Market?

The growth in the swollen knee treatment market is driven by several key factors, including aging populations, rising incidence of orthopedic conditions, growing sports-related injuries, and innovations in biologic and non-invasive therapies. The demand for patient-friendly, effective, and long-lasting treatment solutions is pushing R&D in regenerative medicine, orthobiologics, and smart rehabilitation technologies.

Hospital investments in orthopedic infrastructure, along with the proliferation of specialty clinics and ambulatory surgical centers, are further boosting market accessibility. Technological advances in wearable monitoring and tele-rehabilitation are aligning with remote care trends, making knee care more proactive and personalized. Public and private health insurance support, increased physician training, and expanded patient education are also playing critical roles in the market’s upward trajectory.

SCOPE OF STUDY:

The report analyzes the Swollen Knee Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine, Surgery); Medication (Opioids Medication, Corticosteroids Medication, Other Medications); Surgery (Arthrocentesis Surgery, Arthroscopy Surgery, Knee Replacement Surgery); End-User (Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• AbbVie Inc.
• AstraZeneca
• B. Braun Melsungen AG
• Bayer AG
• BD (Becton Dickinson)
• DePuy Synthes (Johnson & Johnson)
• Eli Lilly and Company
• Exactech Inc.
• Flexion Therapeutics, Inc.
• GlaxoSmithKline plc
• Johnson & Johnson (DePuy)
• Mathys (Enovis/previously Mathys AG)
• Merck & Co., Inc.
• Novartis International AG
• Ossur hf.
• Pfizer Inc.
• Sanofi S.A.
• Smith & Nephew plc
• Stryker Corporation
• Zimmer Biomet

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Swollen Knee Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Osteoarthritis and Sports Injuries Throws the Spotlight on Swollen Knee Therapies
  • Growing Geriatric Population Propels Demand for Minimally Invasive and Drug-Free Treatment Options
  • Expansion in Physiotherapy and Rehabilitation Services Strengthens Role of Non-Surgical Interventions
  • Increased Access to Telehealth Platforms Accelerates Use of Virtual Consultation for Knee Pain Management
  • Advancements in Imaging and Diagnostic Tools Enhance Early Detection and Personalized Treatment of Knee Swelling
  • Demand for Intra-Articular Injections and Hyaluronic Acid Therapy Drives Growth in Outpatient Services
  • Emerging Use of Regenerative Therapies and PRP Injections Creates New Revenue Streams
  • Development of Anti-Inflammatory Topicals and Patches Supports Over-the-Counter Swollen Knee Relief
  • Wearable Compression and Smart Bracing Solutions Gain Traction in Post-Treatment Recovery
  • Rise in Sports Medicine Clinics and Fitness Centers Expands Preventive Care and Recurrence Management
  • Digital Tracking of Swelling and Mobility Progress Enhances Patient Adherence to Therapy Plans
  • Insurance Coverage Expansion in Physical and Non-Surgical Therapies Improves Treatment Accessibility
  • Clinical Research in Targeted Biologic Agents Opens New Frontiers in Advanced Knee Inflammation Control
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Swollen Knee Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Swollen Knee Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Swollen Knee Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Swollen Knee Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Patient-Controlled Analgesia Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Patient-Controlled Analgesia Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Patient-Controlled Analgesia Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Nerve Blocks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Nerve Blocks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Nerve Blocks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Liposomal Bupivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Liposomal Bupivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Liposomal Bupivacaine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Arthroscopy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Arthroscopy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Arthroscopy Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Knee Replacement Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Knee Replacement Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Knee Replacement Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Arthrocentesis Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Arthrocentesis Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Arthrocentesis Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Designated Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Designated Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Designated Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Opioids Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Opioids Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Opioids Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Corticosteroids Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Corticosteroids Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Corticosteroids Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Other Medications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Other Medications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Other Medications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 50: USA Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: USA 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: USA 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Canada 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Canada 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Canada 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• JAPAN
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Japan 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Japan 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Japan 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Japan 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• CHINA
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 86: China Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: China 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: China 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: China 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: China 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• EUROPE
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Swollen Knee Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Swollen Knee Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for Swollen Knee Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Europe 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Europe 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Europe 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• FRANCE
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 113: France Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: France 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: France 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: France 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: France 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• GERMANY
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Germany 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Germany 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Germany 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Germany 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Italy 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Italy 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Italy 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Italy 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 149: UK Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: UK 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: UK 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: UK 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: UK 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Spain 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Spain 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Spain 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Spain 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Russia 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Russia 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Russia 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Russia 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Swollen Knee Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Swollen Knee Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for Swollen Knee Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Australia 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Australia 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Australia 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Australia 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• INDIA
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 224: India Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: India 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: India 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: India 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: India 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: South Korea 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: South Korea 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: South Korea 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: South Korea 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Swollen Knee Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Swollen Knee Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for Swollen Knee Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Latin America 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Latin America 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Latin America 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Argentina 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Argentina 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Argentina 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Argentina 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Brazil 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Brazil 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Brazil 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Brazil 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Mexico 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Mexico 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Mexico 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Mexico 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Swollen Knee Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Swollen Knee Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for Swollen Knee Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Middle East 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Middle East 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Middle East 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Iran 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Iran 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Iran 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Iran 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Israel 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Israel 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Israel 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Israel 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: UAE 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: UAE 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: UAE 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: UAE 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030
• AFRICA
  • Swollen Knee Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Swollen Knee Treatment by Type - Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Africa 16-Year Perspective for Swollen Knee Treatment by Type - Percentage Breakdown of Value Sales for Medication, Patient-Controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery for the Years 2014, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Swollen Knee Treatment by Surgery - Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Africa 16-Year Perspective for Swollen Knee Treatment by Surgery - Percentage Breakdown of Value Sales for Arthroscopy Surgery, Knee Replacement Surgery and Arthrocentesis Surgery for the Years 2014, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Swollen Knee Treatment by End-user - Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 406: Africa 16-Year Perspective for Swollen Knee Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Designated Clinics End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for Swollen Knee Treatment by Medication - Opioids Medication, Corticosteroids Medication and Other Medications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 409: Africa 16-Year Perspective for Swollen Knee Treatment by Medication - Percentage Breakdown of Value Sales for Opioids Medication, Corticosteroids Medication and Other Medications for the Years 2014, 2025 & 2030

IV. COMPETITION